Pricing Log in Create free account
Thursday 12 November 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY

Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.

Revenue
+14.0%
EPS
−277.9%
Free cash flow
−233.0%
Total debt
−10.5%

Quarter to September 2026, against a year earlier

121.89 0.38 −0.31%
Market cap
$24.9B
P/E
58.1×
Fwd P/E
57.3×
Dividend yield
—
F-score
9/9
ROIC
21.6%
Net debt / EBITDA
−2.2×
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Incyte Corporation (INCY) EV/Sales

Alert me on EV/Sales

As of 12 November 2026, Incyte Corporation (INCY) trades at a EV/Sales of 3.5×. Over the past ten years it has ranged from 1.9× (April 2025) to 36.5× (September 2015); the current reading is higher than 28% of that period. That is below the Biotechnology industry median of 8.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.1× 6.51%
FY2024 2.9× (3.61%)
FY2023 3.0× (30.00%)
FY2022 4.3× (8.30%)
FY2021 4.6× (28.01%)
FY2020 6.5× (16.56%)
FY2019 7.7× 20.38%
FY2018 6.4× (49.36%)
FY2017 12.7× (26.41%)
FY2016 17.2× (32.97%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.5× 10.79%
Jun 2026 3.1× 13.50%
Mar 2026 2.8× (9.91%)
Dec 2025 3.1× 7.51%
43 more quarters

Against its own ten years

Low 1.9× High 36.5×
Ten-year median 6.6×
Current reading's percentile 30

EV/Sales against peers

Company EV/Sales
BNTX BioNTech SE Sponsored ADR compare 1.7×
INCY Incyte Corporation 3.5×
ALNY Alnylam Pharmaceuticals, Inc. compare 3.7×
JAZZ Jazz Pharmaceuticals PLC compare 3.9×
EXEL Exelixis, Inc. compare 6.6×
GMAB Genmab A/S Sponsored ADR compare 8.1×
ASND Ascendis Pharma A/S compare 13.9×
INSM Insmed, Inc. compare 16.7×
ROIV Roivant Sciences Ltd. compare 609×
Biotechnology industry median 8.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on INCY